Evidence map›Paper›PMID 35214566›Full record

ArticleSensors (Basel, Switzerland)2022

A Machine Learning Approach to Minimize Nocturnal Hypoglycemic Events in Type 1 Diabetic Patients under Multiple Doses of Insulin.

Adrià Parcerisas, Ivan Contreras, Alexia Delecourt, Arthur Bertachi, Aleix Beneyto, Ignacio Conget, Clara Viñals, Marga Giménez, Josep Vehi

Open access · goldAbstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Artificial Intelligence to Diagnose Complications of Diabetes.Journal of diabetes science and technology · 2025
    Review
  6. Article
  7. Nocturnal Hypoglycemia in the Era of Continuous Glucose Monitoring.Journal of diabetes science and technology · 2024
    Review
  8. Article
  9. Predicting Glucose Values: A New Era for Continuous Glucose Monitoring.Journal of diabetes science and technology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Managing Severe Hypoglycaemia in Patients with Diabetes: Current Challenges and Emerging Therapies.Diabetes, metabolic syndrome and obesity : targets and therapy · 2023
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Adrià ParcerisasInstitut d'Informàtica i Aplicacions, Universitat de Girona, 17003 Girona, Spain.ORCID 0000-0003-4364-1601
Ivan ContrerasInstitut d'Informàtica i Aplicacions, Universitat de Girona, 17003 Girona, Spain.ORCID 0000-0001-6896-818X
Alexia DelecourtInstitut d'Informàtica i Aplicacions, Universitat de Girona, 17003 Girona, Spain.
Arthur BertachiCampus Guarapuava, Federal University of Technology-Paraná (UTFPR), Guarapuava 85053-525, Brazil.
Aleix BeneytoInstitut d'Informàtica i Aplicacions, Universitat de Girona, 17003 Girona, Spain.ORCID 0000-0001-8207-2259
Ignacio CongetEndocrinology and Diabetes Unit, Hospital Clínic, 08036 Barcelona, Spain.
Clara ViñalsEndocrinology and Diabetes Unit, Hospital Clínic, 08036 Barcelona, Spain.ORCID 0000-0002-6888-0396
Marga GiménezEndocrinology and Diabetes Unit, Hospital Clínic, 08036 Barcelona, Spain.ORCID 0000-0003-2976-1690
Josep VehiInstitut d'Informàtica i Aplicacions, Universitat de Girona, 17003 Girona, Spain.ORCID 0000-0001-6884-9789
Universitat de Girona · ESCentro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas · ESHospital Clínic de Barcelona · ESUniversidade Tecnológica Federal do Paraná · BR

Funding

European Regional Development Fund PROD 00041Government of Catalonia 2017SGR1551Spanish Ministry of Science and Innovation PID2019-107722RBSpanish Ministry of Science and Innovation PID2020-117171RA-I00
6 · The paper itself

Abstract

Nocturnal hypoglycemia (NH) is one of the most challenging events for multiple dose insulin therapy (MDI) in people with type 1 diabetes (T1D). The goal of this study is to design a method to reduce the incidence of NH in people with T1D under MDI therapy, providing a decision-support system and improving confidence toward self-management of the disease considering the dataset used by Bertachi et al. Different machine learning (ML) algorithms, data sources, optimization metrics and mitigation measures to predict and avoid NH events have been studied. In addition, we have designed population and personalized models and studied the generalizability of the models and the influence of physical activity (PA) on them. Obtaining 30 g of rescue carbohydrates (CHO) is the optimal value for preventing NH, so it can be asserted that this is the value with which the time under 70 mg/dL decreases the most, with almost a 35% reduction, while increasing the time in the target range by 1.3%. This study supports the feasibility of using ML techniques to address the prediction of NH in patients with T1D under MDI therapy, using continuous glucose monitoring (CGM) and a PA tracker. The results obtained prove that BG predictions can not only be critical in achieving safer diabetes management, but also assist physicians and patients to make better and safer decisions regarding insulin therapy and their day-to-day lives.

Indexed as

Diabetes Mellitus, Type 1Blood GlucoseBlood Glucose Self-MonitoringHumansHypoglycemic AgentsInsulinInsulin Infusion SystemsMachine LearningBlood GlucoseHypoglycemic AgentsInsulinhypoglycemiamachine learningmultiple daily injectionsprediction modelsupport vector machinetype 1 diabetes

Identifiers

PMID35214566
PMCPMC8876195
OpenAlexW4213089406

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.